SCHEMBL13870924

SCHEMBL13870924

COc1cccc(-c2ccc3c(OC)cc(OC)cc3n2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.66
KDM4E B2RXH2 5/20 0.66
ALDH1A1 P00352 4/20 0.66
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
LMNA P02545 3/20 0.50
HPGD P15428 3/20 0.50
PDGFRB P09619 2/20 0.50
PDGFRA P16234 1/20 0.50
MAP4K4 O95819 1/20 0.49
MAPT P10636 3/20 0.49
HTT P42858 1/20 0.49
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
VDR P11473 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2B6 P20813 1/20 0.47
AHR P35869 1/20 0.47
NR1I3 Q14994 1/20 0.47
TOP1 P11387 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13870910 0.89 KDM4E (0.59) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL8887700 0.88 SMN1; SMN2 (0.78) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL16487812 0.85 SMN1; SMN2 (0.55) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL13870941 0.83 SMN1; SMN2 (0.52) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL13870928 0.82 KDM4E (0.53) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL13870911 0.81 KDM4E (0.56) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL13870935 0.81 PDGFRB (0.61) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL15579401 0.80 KDM4E (0.73) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL6913447 0.79 KDM4E (1.00) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL13870891 0.79 MAP4K4 (0.48) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 SMN1; SMN2 4169/4885KDM4E 2874/4885ALDH1A1 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.